I am proposing that all companies currently engaged in developing biosimilars join hands with their regulatory and scientific ...
Johnson & Johnson JNJ announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving ...
The net asset value (NAV) per unit of the Baltic Horizon Fund (the Fund) amounted to EUR 0.7080 at the end of October 2024 (0.7099 as of 30 September 2024). The month-end total net asset value of the ...
Hatim Husain, MD, discusses how the implementation of proactive prophylaxis strategies for patients taking amivantamab, ...
In the latest episode of Oncology Unscripted, Dr. John Marshall addresses critical issues concerning the dosing practices in oncology, particularly questioning the prevailing approach of using maximum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback